Dr. Monare Thulo is a medical doctor and researcher with a robust background in biochemistry and structural biology. He is currently a Project Manager/Post-Doctorate Researcher at Wits Health Consortium, Wits Vaccine and Infectious Disease Analytics Units (Wits VIDA), a role he began in January 2025, where he leads the adult antimicrobial resistance surveillance project with particular focus on ESKAPE pathogens.  

Previously, he served as an Intern Medical Officer at Sebokeng Hospital from January to December 2024. Dr. Thulo’s research experience includes a Postdoctoral Fellowship at the Protein Structure-Function Research Unit, University of the Witwatersrand (2019-2023), and a Research Scientist position at Buboo Bioinnovations (2020-2021). He also held roles as Chief Invigilator at the University of the Witwatersrand (2017-2018) and Research Assistant at the National University of Lesotho (2014). 

Academically, Dr. Thulo holds a Bachelor of Medicine and Bachelor of Surgery (MBBCH) (2020-2023) and a PhD in Medical Biochemistry & Structural Biology (2014-2019) from the University of the Witwatersrand. His doctoral research focused on the structural and functional characterization of FOXP1 and FOXP2 near-full length variants and their protein-protein interactions. He gained expertise in technologies such as Isothermal titration calorimetry (ITC), fluorescence anisotropy (FA), surface plasmon resonance (SPR), spectroscopy, dynamic light scattering, and small angle x-ray scattering (SAXS). He also earned a BSc in Chemical Technology from the National University of Lesotho (2009-2014).  

Dr. Thulo’s current research centers on exploring antimicrobial resistance. He is interested in investigating how cellular evolution, biochemistry, and metabolism interact to drive drug tolerance, resistance, and persistence. The ultimate objective of his work is to uncover new therapeutic approaches that are less susceptible to drug resistance, and to deepen the understanding of clonal evolution and single-cell biology.